3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
32
Observational
6
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
13
Gynecologic
4
Genitourinary
4
Thoracic
3
Gastrointestinal
3
Lymphoid
2
Breast
2
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Dermatologic
1
CNS
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia, Myeloid, Acute
7
Myelodysplastic Syndromes
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Primary Myelofibrosis
3
Lymphoma
3
Leukemia
3
Hematologic Neoplasms
3
Blast Crisis
3
Precancerous Conditions
2
Polycythemia Vera
2
Multiple Myeloma
2
Mastocytosis, Systemic
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Mast-Cell
2
Immunologic Deficiency Syndromes
2
Graft vs Host Disease
2
Waldenstrom Macroglobulinemia
1
Thalassemia
1
Sarcoma
1
Recurrence
1
Preleukemia
1
Pancytopenia
1
Osteosclerosis
1
Osteopetrosis
1
Osteochondrodysplasias
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasms
1
Interventions
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Sarcoma
×
Myeloid
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available